|
gptkbp:instanceOf
|
Infectious disease
|
|
gptkbp:affects
|
gptkb:Humans
|
|
gptkbp:annualCasesWorldwide
|
11–20 million
|
|
gptkbp:annualDeathsWorldwide
|
128,000–161,000
|
|
gptkbp:antibioticResistance
|
Increasing
|
|
gptkbp:associatedWith
|
gptkb:Salmonellosis
gptkb:Paratyphoid_fever
|
|
gptkbp:canBeChronic
|
Yes
|
|
gptkbp:carrierExample
|
gptkb:Mary_Mallon
|
|
gptkbp:causedBy
|
gptkb:Salmonella_enterica_serotype_Typhi
|
|
gptkbp:commonIn
|
Developing countries
|
|
gptkbp:complication
|
Sepsis
Encephalopathy
Intestinal perforation
|
|
gptkbp:diagnosedBy
|
Blood culture
Bone marrow culture
Stool culture
|
|
gptkbp:firstDescribed
|
gptkb:William_Budd
1850s
|
|
gptkbp:hasCarrierState
|
Yes
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Typhoid Fever
|
|
gptkbp:ICD-10_code
|
A01.0
|
|
gptkbp:incubationPeriod
|
6-30 days
|
|
gptkbp:MeSH_ID
|
D014435
|
|
gptkbp:mortalityRate
|
10-20% untreated
<1% with treatment
|
|
gptkbp:notableOutbreaks
|
gptkb:Mary_Mallon_(Typhoid_Mary)
|
|
gptkbp:prevention
|
gptkb:Typhoid_vaccine
Safe drinking water
Improved sanitation
|
|
gptkbp:publicHealthConcern
|
Yes
|
|
gptkbp:rareIn
|
Developed countries
|
|
gptkbp:symptom
|
Fever
Headache
Constipation
Diarrhea
Abdominal pain
Rash (rose spots)
|
|
gptkbp:transmission
|
Fecal-oral route
|
|
gptkbp:treatment
|
gptkb:Ciprofloxacin
gptkb:Antibiotics
gptkb:Azithromycin
gptkb:Ceftriaxone
|
|
gptkbp:vaccineType
|
Conjugate vaccine
Live attenuated
Vi polysaccharide
|
|
gptkbp:WHOClassification
|
Neglected tropical disease
|
|
gptkbp:bfsParent
|
gptkb:disease
|
|
gptkbp:bfsLayer
|
4
|